Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 2, 2015, Pages 211-220

  Yang, Z ^a   Li, D M ^a   Xie, Q ^a   Dai, D Q ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; Gastric cancer; Gene expression, DNA methylation; TCF21

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 21; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; TCF21 PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; DNA METHYLATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING; CANCER GRADING; CANCER STAGING; ENZYME IMMUNOASSAY; EPIGENETICS; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; TISSUE MICROARRAY; TUMOR INVASION;

AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; DNA METHYLATION; EPIGENOMICS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84921030022     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1809-x     Document Type: Article

References (34)

1. Anglim PP, Galler JS, Koss MN, Hagen JA, Turla S et al (2008) Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol Cancer 7:62. doi:10.1186/1476-4598-7-62
2. Arab K, Smith LT, Gast A, Weichenhan D, Huang JP et al (2011) Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis 32:1467–1473
3. Baum B, Settleman J, Quinlan MP (2008) Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19:294–308
4. Bhandari RK, Sadler-Riggleman I, Clement TM (2011) Skinner MK (2011) Basic helix-loop-helix transcription factor TCF21 is a downstream target of the male sex determining gene SRY. PLoS One 6(e19935):17. doi:10.1371/journal.pone.0019935
5. Costa VL, Henrique R, Danielsen SA, Eknaes M, Patrício P et al (2011) TCF21 and PCDH17 methylation: an innovative panel of biomarkers for a simultaneous detection of urological cancers. Epigenetics 6:1120–1130
6. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362
7. Gopalakrishnan S, Van Emburgh BO, Robertson KD (2008) DNA methylation in development and human disease. Mutat Res 647:30–38
8. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140–D144
9. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318
10. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA et al (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213:374–383
11. Jemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
12. Kiemer AK, Takeuchi K, Quinlan MP (2001) Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene 20:6679–6688
13. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847
14. Lu J, Richardson JA, Olson EN (1998) Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech Dev 73:23–32
15. Lu J, Chang P, Richardson JA, Gan L, Weiler H et al (2000) The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc Natl Acad Sci USA 97:9525–9530
16. Lu JR, Bassel-Duby R, Hawkins A, Chang P, Valdez R et al (2002) Control of facial muscle development by MyoR and capsulin. Science 298:2378–2381
17. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y et al (2007) Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26:6099–6105
18. Meuwissen R, Berns A (2005) Mouse models for human lung cancer. Genes Dev 19:643–664
19. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K (2004) Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 64:2024–2029
20. Prindull G, Zipori D (2004) Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 103:2892–2899
21. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J et al (1999) The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126:5771–5783
22. Richards KL, Zhang B, Sun M, Dong W, Churchill J et al (2011) Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer 117:606–617
23. Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E et al (2008) Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiol Biomarkers Prev 17:995–1000
24. Smith LT, Lin M, Brena RM, Lang JC, Schuller DE et al (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci USA 103:982–987
25. Su Z, Xia J, Zhao Z (2011) Functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome. BMC Genom 12(Suppl 5):S15
26. Tessema M, Belinsky SA (2008) Mining the epigenome for methylated genes in lung cancer. Proc Am Thorac Soc 5:806–810
27. Tessema M, Willink R, Do K, Yu YY, Yu W et al (2008) Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res 68:1707–1714
28. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257–2261
29. Weiss D, Basel T, Sachse F, Braeuninger A, Rudack C (2011) Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation. Mol Carcinog 50:680–688
30. Weiss D, Stockmann C, Schrödter K, Rudack C (2013) Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma. Cell Oncol 36:213–224
31. Welch DR, Rinker-Schaeffer CW (1999) What defines a useful marker of metastasis in human cancer? J Natl Cancer Inst 91:1351–1353
32. Ye YW, Jiang ZM, Li WH, Li ZS, Han YH et al (2012) Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma. Neoplasma 59:599–605
33. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW (2000) Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 92:1717–1730
34. Zhang H, Guo Y, Shang C, Song Y, Wu B (2012) miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. Urology 80:1298–1302